Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/25/2025

Nystatin for Vaginal Yeast Infection

Efficacy of Nystatin vs. Other Treatments

  • Topically applied azole drugs are more effective than nystatin for treating vaginal yeast infections, with azole medications demonstrating superior efficacy with 80-90% relief of symptoms and negative cultures among patients who complete therapy 1, 2, 3
  • Nystatin vaginal tablets (100,000-unit) are included in treatment guidelines for vulvovaginal candidiasis (VVC), but require a longer treatment duration (14 days) compared to most azole medications 1, 2

Treatment Algorithm for Vaginal Yeast Infections

  • The Centers for Disease Control and Prevention (CDC) recommends topical azole medications (intravaginal formulations) as first-line treatments, including clotrimazole 1% cream for 7-14 days or vaginal tablets (100mg for 7 days or 500mg as single dose) 1, 4
  • The CDC also recommends oral azole medication, such as fluconazole 150mg oral tablet as a single dose, as a first-line treatment option 1, 4
  • Nystatin 100,000-unit vaginal tablet, one tablet for 14 days, is considered an alternative treatment when azoles cannot be used 1, 4

Special Considerations

  • The CDC notes that non-albicans VVC, particularly C. glabrata, may require different treatment approaches 5
  • For women experiencing recurrent VVC (RVVC), the CDC recommends initial induction therapy followed by maintenance therapy for at least 6 months, and considers nystatin vaginal suppositories as a maintenance regimen if non-albicans Candida continues to recur 5
  • Complicated VVC (severe symptoms, immunocompromised host, or non-albicans species) requires longer duration of therapy (10-14 days), with azoles remaining first-line, but nystatin may be considered for azole-resistant cases 1, 4

Common Pitfalls and Caveats

  • The CDC advises that self-medication with over-the-counter preparations should only be advised for women previously diagnosed with VVC who experience recurrence of the same symptoms, and that any woman whose symptoms persist after using OTC preparations or who experiences symptom recurrence within 2 months should seek medical care 1, 2, 4
  • The CDC also notes that identifying Candida in the absence of symptoms should not lead to treatment, as approximately 10-20% of women normally harbor Candida species in the vagina, and that oil-based creams and suppositories may weaken latex condoms and diaphragms 1, 4

Treatment of Genital Yeast Overgrowth

First-Line Treatment Options

  • For severe infection, the Centers for Disease Control and Prevention recommends a longer duration of therapy (7-14 days) with topical agents or fluconazole 150mg orally every 72 hours for a total of 2-3 doses 6

Special Situations

  • Recurrent Vulvovaginal Candidiasis (RVVC) is defined as ≥3 symptomatic episodes in 12 months, according to the Infectious Diseases Society of America 7
  • For RVVC, the Centers for Disease Control and Prevention recommends initial induction therapy with 7-14 days of topical azole or oral fluconazole, followed by maintenance therapy with weekly fluconazole 150mg for 6 months 6
  • For non-albicans Candida species, the Centers for Disease Control and Prevention recommends a longer duration (7-14 days) with a non-fluconazole azole drug as first-line therapy 6
  • For pregnant women, the Centers for Disease Control and Prevention recommends only topical azole therapies applied for 7 days, and oral fluconazole should be avoided during pregnancy 6

Treatment of Genital Yeast Infections with Nystatin

Efficacy of Nystatin

  • Nystatin may be more effective than fluconazole in treating C. glabrata or azole-resistant infections, with a cure rate of 64.3% for C. glabrata infections compared to 12.5% with fluconazole 8
  • Testing at vaginal pH 4 reveals clinically relevant azole resistance, particularly with C. glabrata showing >388-fold higher MIC for terconazole, which may support the use of nystatin in these cases 8

Treatment Guidelines

  • The CDC recommends considering nystatin as an alternative treatment for genital yeast infections when azoles cannot be used, although the exact recommendation is not specified in the provided text, nystatin 100,000-unit vaginal tablet for 14 days can be considered 8